IDEXX Laboratories, Inc. vs Seagate Technology Holdings PLC — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Seagate Technology Holdings PLC trades at $783 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 4.4× IDEXX Laboratories, Inc.'s market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Seagate Technology Holdings PLC for 41 Days on average.
| IDXX | STX | |
|---|---|---|
Market Cap | $40.43B | $176.19B |
Volume | 692,164 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $766.68 | $1.09K |
52-Week Low | $504.70 | $211.63 |
Typical Hold Time | 46 Days | 41 Days |
Enterprise Value | $41.32B | $178.34B |
Dividend Yield | — | 0.38% |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Seagate Technology (STX) trades at $774.83, down 4.03% amid concerns about increased competition from Toshiba's planned hard drive production expansion. The stock shows strong fundamental performance with Q2 2026 EPS of $5.71 beating expectations by 12%, and robust profitability metrics including 26.11% net income margin and 371.53% ROE. Technical indicators signal bearish momentum with price below key pivot points, though RSI suggests potential oversold conditions. Analyst consensus remains positive with 54% buy ratings and $1,130 price target representing 46% upside potential.
STX presents a compelling growth story driven by AI storage demand, but faces near-term headwinds from competitive threats. The company's strong earnings beat streak and projected 2026 revenue growth to $12.2B support long-term optimism, while current valuation multiples appear elevated. Key risks include pricing pressure from new capacity and dependency on AI infrastructure spending cycles.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →